C018 Updates in Hair Disorders
DESCRIPTION
Tuition fee and ticket required for admission
A wide spectrum of scalp disorders will be covered including alopecia areata, androgenetic hair loss, acute and chronic telogen effluvium and cicatricial alopecia, including lichen planopilaris and frontal fibrosing alopecia. Alopecias in cancer patients and survivors will be discussed. The efficacy of the latest state of the art treatments such as JAK inhibitors, topical and intralesional anti-androgens will be evaluated. Trichoscopy and scalp pathology in distinguishing scalp disorders will be emphasized. An update on surgical techniques in hair transplantation will be presented. Ethnic hair disorders such as central centrifugal cicatricial alopecia in terms of recognition and treatment will be covered.
LEARNING OBJECTIVES
Diagnose and manage cicatricial alopecias, alopecia areata, and androgenetic hair loss.
Distinguish scalp disorders by trichoscopy and scalp pathology.
Recognize ethnic hair disorders.
SCHEDULE
8:00 PM
Lichen Planopilaris Update: What I do
Jerry Shapiro, MD, FAAD
8:15 PM
JAK inhibitors for alopecia areata: maintenance, downtitration, safety and what is the fastest way to get your chosen JAK inhibitor to your alopecia areata patient
Brett Andrew King, MD, PhD, FAAD
8:30 PM
Hair Surgery Update
Sergio Vano-Galvan, MD, PhD, IFAAD
8:45 PM
Dermoscopy Update in the evaluation and treatment of hair loss
Lidia Rudnicka, MD, PhD, IFAAD
9:00 PM
The long and winding road of minoxidil in the evaluation and treatment of hair loss
Elise A. Olsen, MD, FAAD
9:15 PM
The Hair Cycle Rules
George Cotsarelis, MD, FAAD
9:30 PM
Central Centrifugal Cicatricial Alopecia: Latest Data
Pearl E. Grimes, MD, FAAD
9:45 PM
Hair Loss in Women: My approach for general hair loss in women.
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
10:00 PM
Aiding the dermatopathologist to deliver a more accurate meaningful report
Mariya Miteva, MD
10:15 PM
Frontal Fibrosing Alopecia: My Approach
Rodrigo Pirmez, MD
10:30 PM
Mesotherapy for Androgenetic Alopecia
10:45 PM
Alopecia in cancer patients and survivors
Azael David Freites Martinez, MD, IFAAD
SPEAKERS
George Cotsarelis, MD, FAAD
Azael David Freites Martinez, MD, IFAAD
Pearl E. Grimes, MD, FAAD
Brett Andrew King, MD, PhD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Mariya Miteva, MD
Elise A. Olsen, MD, FAAD
Rodrigo Pirmez, MD
Lidia Rudnicka, MD, PhD, IFAAD
Jerry Shapiro, MD, FAAD
Sergio Vano-Galvan, MD, PhD, IFAAD
HANDOUTS
SPEAKER DISCLOSURES
George Cotsarelis, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Almirall – Investigator(Grants/Research Funding); Follica – Advisory Board(Honoraria), Founder(Stock Options); GlaxoSmithKline – Speaker(Honoraria); JW Pharmaceutical Corp – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding);
Azael David Freites Martinez, MD, IFAAD
I.F.C., S.A. – Speaker(Honoraria); ISDIN – Speaker/Faculty Education(Honoraria); Janssen Pharmaceuticals, Inc – Speaker/Faculty Education(Fees); L'Oréal France – Investigator(Fees); sanofi-aventis – Consultant(Fees);
Pearl E. Grimes, MD, FAAD
AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); AnaptysBio – Consultant(Fees), Investigator(Fees); Arena Pharmaceuticals – Consultant(Fees), Investigator(Fees); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Concert Pharmaceuticals – Consultant(Fees), Investigator(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Equillium, Inc. – Consultant(Fees); Horizon Pharma, Inc. – Consultant(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees), Investigator(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Mariya Miteva, MD
Eli Lilly – Investigator(Grants/Research Funding); Informa – Other(Fees); Pfizer Inc. – Investigator(Grants/Research Funding);
Elise A. Olsen, MD, FAAD
Affimed – Data Safety Monitoring Board(Honoraria); Allergan, Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Arena Pharmaceuticals – Consultant(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cassiopia – Consultant(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Equillium, Inc. – Consultant (1099 relationship)(Honoraria); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Honoraria); Kyowa Kirin – Consultant(Honoraria), Investigator(Grants/Research Funding); Myovant Sciences – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sologenix – Consultant(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);
Lidia Rudnicka, MD, PhD, IFAAD
La Roche-Posay Laboratoire Pharmaceutique – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Novartis – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Speaker/Faculty Education(Other Financial Benefit); UCB – Speaker(Honoraria);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);
Sergio Vano-Galvan, MD, PhD, IFAAD
AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);